Court rejects Healthscope
Tuesday, 02 September, 2008
The NSW Supreme Court has rejected Healthscope's [ASX: HSP] appeal for a break free from Symbion Health.
Healthscope, a private hospital operator which also owns some pathology businesses, had argued that pathology specialist Symbion should pay the company $19.5 million after reneging on a deal which would have seen Healthscope acquire Symbion's diagnostics business.
The court ordered that the break fee was not required. Healthscope is planning to lodge an appeal with the NSW Court of Appeal.
Shingles vaccine may lower risk of dementia, heart disease
It turns out that the shingles vaccine may have public-health benefits beyond its intended...
How does the brain evaluate rewards?
Neuroscientists have shown how nerve cells in the amygdala not only encode the probability and...
Breakthrough drug prevents long COVID symptoms in mice
Mice treated with the antiviral compound were protected from long-term brain and lung dysfunction...
